Surveillance for AIDS in a central African city. Kinshasa, Zaire

JAMA. 1986 Jun 20;255(23):3255-9.

Abstract

Surveillance for acquired immunodeficiency syndrome (AIDS) in Kinshasa, Zaire, was initiated in July 1984, using a modified version of the case definition developed by the Centers for Disease Control. During the first eight months, 332 patients met all clinical and laboratory criteria; surveillance information was available for 295 (89%) of these patients. Of the sera tested from these patients, 99% had antibodies to human T-cell lymphotropic virus type III/lymphadenopathy-associated virus by both enzyme-linked immunosorbent assay and Western blot procedures. The male-female case ratio was 1:1.1; the mean age of patients was 33.6 years (median, 32 years; range, 1.5 to 64 years); and men were significantly older than women (mean, 37.4 vs 30.0 years). The estimated incidence rate for adults in Kinshasa is 380 cases per 1 million people per year. Peak age-specific incidence rates for men and women occurred among the 30- to 39-year age group, although the rate for men in this age group was 24% higher than the rate for women (786 vs 601 per 1 million). A reasonable estimate of the current annual incidence of AIDS is 550 to 1,000 cases per 1 million people. Surveillance of AIDS in Zaire provides important information on transmission patterns and rates in Africa.

MeSH terms

  • Acquired Immunodeficiency Syndrome / diagnosis
  • Acquired Immunodeficiency Syndrome / epidemiology*
  • Adolescent
  • Adult
  • Age Factors
  • Antibodies, Viral / analysis
  • Child
  • Child, Preschool
  • Deltaretrovirus / immunology
  • Democratic Republic of the Congo
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • HIV Antibodies
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Population Surveillance
  • Sex Factors
  • T-Lymphocytes / classification

Substances

  • Antibodies, Viral
  • HIV Antibodies